Drug reference

mavacamten

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 1410

Review source pages for extracted sections and age labels.

Overview

Names and pronunciation

(MAV′a′KAM′ten) Camzyos

PDF page 1410

Functional class

Func. class.: Cardiac myosin inhibitor

PDF page 1410

Uses

USES: Adults with symptomatic New York Heart Association (NYHA) class II- III obstructive hypertrophic cardiomy- opathy (HCM) to improve functional ca- pacity and symptoms

PDF page 1410

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES Check manufacturer’s information

PDF page 1410

Available forms

Available forms: Capsules: 2.5, 5, 10, 15 mg

PDF page 1410

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.

Drug reference

mavacamten

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 1410

Review source pages for extracted sections and age labels.

Overview

Names and pronunciation

(MAV′a′KAM′ten) Camzyos

PDF page 1410

Functional class

Func. class.: Cardiac myosin inhibitor

PDF page 1410

Uses

USES: Adults with symptomatic New York Heart Association (NYHA) class II- III obstructive hypertrophic cardiomy- opathy (HCM) to improve functional ca- pacity and symptoms

PDF page 1410

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES Check manufacturer’s information

PDF page 1410

Available forms

Available forms: Capsules: 2.5, 5, 10, 15 mg

PDF page 1410

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.